H
HUTCHMED (China) Ltd
LSE:HCM
HUTCHMED (China) Ltd
LSE:HCM
Price:
219
GBX
4.29%
Market Closed
Market Cap:
£1.9B
Relative Value
The Relative Value of one HCM stock under the Base Case scenario is hidden GBX. Compared to the current market price of 219 GBX, HUTCHMED (China) Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
HCM Relative Value
HIDDEN
Multiples Across Competitors
HCM Competitors Multiples
HUTCHMED (China) Ltd Competitors
HUTCHMED (China) Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| HK |
H
|
HUTCHMED (China) Ltd
LSE:HCM
|
20.3B GBP | 4.3 | 5.6 | -177.1 | -67.3 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
976.4B USD | 15 | 47.3 | 31.9 | 33.9 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
590.4B USD | 6.3 | 22 | 15.3 | 18.8 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
294.6B CHF | 4.8 | 31.3 | 13.2 | 15.4 | |
| CH |
|
Novartis AG
SIX:NOVN
|
248.5B CHF | 5.7 | 22.9 | 14.1 | 18.2 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
236B GBP | 5.4 | 31.1 | 17.2 | 24.2 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
306.5B USD | 4.7 | 16.8 | 10.5 | 12.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.5 | 10.4 | 7.7 | 9.1 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.2B USD | 2.5 | 19.8 | 7.4 | 9.9 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
123.7B USD | 2.6 | 17.5 | 7.3 | 9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
